Critical perspectives on CSR and development:: what we know, what we don't know, and what we need to know

被引:184
|
作者
Prieto-Carron, Marina [1 ]
Lund-Thomsen, Peter [1 ]
Chan, Anita [1 ]
Muro, Ana [1 ]
Bhushan, Chandra [1 ]
机构
[1] Univ Bristol, Sch Geog Studies, Bristol BS8 1TH, Avon, England
关键词
D O I
10.1111/j.1468-2346.2006.00581.x
中图分类号
D81 [国际关系];
学科分类号
030207 ;
摘要
The May 2005 issue of International Affairs addressed the theme of critical perspectives on Corporate Social Responsibility (CSR) in the developing world. The aim of this article is to take the debate a step further. Five researchers and practitioners on corporate social responsibility and development in various regions in the developing world-Central America, Pakistan, China, Vietnam, Argentina and India-using knowledge gained by their empirical research, argue that the management-oriented perspective on CSR and development is one-sided. While recognizing that critical approaches to the question have emerged, there is still a need to know which issues should form part of a critical research agenda on CSR and development. In this article the authors seek to fill this gap in order to facilitate a more in-depth investigation of what CSR initiatives can or cannot achieve in relation to improving conditions of workers and communities in the global South. They suggest that a critical research agenda on CSR and development should encompass four areas: a) the relationship between business and poverty reduction; b) the impact of CSR initiatives; c) governance dimensions of CSR; and d) power and participation in CSR. Such an alternative critical approach focuses on society's most vulnerable groups and adopts a 'people-centred' perspective as a counterbalance to the dominant 'business case' perspective. The authors conclude that this has significant implications for CSR practice.
引用
收藏
页码:977 / +
页数:12
相关论文
共 50 条
  • [21] Metabolic syndrome - What we know and what we don't know
    Ritz, Eberhard
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1619 - 1623
  • [22] "Tau oligomers," what we know and what we don't know
    Sahara, Naruhiko
    Avila, Jesus
    [J]. FRONTIERS IN NEUROLOGY, 2014, 5
  • [23] Corporate governance: what we know and what we don't know
    Elston, Julie
    [J]. JOURNAL OF INDUSTRIAL AND BUSINESS ECONOMICS, 2019, 46 (02): : 147 - 156
  • [24] What we know and what we don't know about the universe
    Gleiser, M
    [J]. INTERNATIONAL JOURNAL OF MODERN PHYSICS D, 2004, 13 (07): : 1381 - 1388
  • [25] Dialyzer reuse: What we know and what we don't know
    Kaplan, AA
    [J]. SEMINARS IN DIALYSIS, 2000, 13 (05) : 271 - 274
  • [26] Corporate governance: what we know and what we don’t know
    Julie Elston
    [J]. Journal of Industrial and Business Economics, 2019, 46 : 147 - 156
  • [27] Business and IT Alignment: What we know and what we don't know
    Silvius, A. J. Gilbert
    [J]. 2009 INTERNATIONAL CONFERENCE ON INFORMATION MANAGEMENT AND ENGINEERING, PROCEEDINGS, 2009, : 558 - 563
  • [28] Online Learning: What We Know and What We Don't Know
    Van Wart, Montgomery
    [J]. INTERNATIONAL JOURNAL OF ADULT EDUCATION AND TECHNOLOGY-IJAET, 2022, 13 (02):
  • [29] Virtual Teams: What We Know, What We Don't Know
    Pinsonneault, Alain
    Caya, Olivier
    [J]. INTERNATIONAL JOURNAL OF E-COLLABORATION, 2005, 1 (03) : 1 - 16
  • [30] Neprilysin Inhibition: What We Know and What We Don't Know
    Buttrick, Peter
    [J]. JOURNAL OF CARDIAC FAILURE, 2018, 24 (04) : 276 - 277